All posts by imreal

Health

American College of Lifestyle Medicine to Honor International Public Health Leader and North Karelia Project Director Pekka Puska with Inaugural Dr. Ancel Keys Award

Leave a comment


https://www.prweb.com/

Professor Pekka Puska

“Like Ancel Keys, Professor Puska has impacted and saved the lives of so many as a leader and contributor to public health and policy.”


ST. LOUIS (PRWEB)

The American College of Lifestyle Medicine (ACLM) today announced that Pekka Puska, MD, PhD, MPolSc, a Finnish professor, physician and former member of the Finnish Parliament, will be awarded the medical professional society’s first-ever Dr. Ancel Keys Award. The award will be were presented during ACLM’s sold-out 2019 Lifestyle Medicine Conference at its annual Awards Banquet on Tuesday, Oct. 29 in Orlando, FL.

Puska has had a significant influence on public health research and practice in Finland and globally for several decades. He was, for 25 years, the Director and Principal Investigator of the North Karelia Project for prevention of cardiovascular diseases in North Karelia and later on in all Finland. Within 35 years, an over 85 percent decline in annual heart disease mortality among the working age population and a dramatic general improvement in public health took place. Turning an area in Finland with the highest heart disease death rate into a country with one of the lowest, the project is widely seen as a model for successful population-based prevention of cardiovascular and other noncommunicable diseases (NCD).

The Dr. Ancel Keys Award was established to recognize a person who has made significant contributions to thought, evidence, practice and policy through research and the application of scientific principles, with particular emphasis on public health issues and population science. The recipient must be highly respected through research and publications as a leader in epidemiology, biostatistics and nutrition, with concern for public as well as individual health. The recipient must have shown courage in taking an evidence-based public policy stance. It will be awarded by ACLM every three years.

The Keys Award is named in honor of Ancel Keys, who started his career in physiology and moved into public health with experiments to meet wartime needs for survival rations (the “K-ration”) and to re-nourish the starving survivors of war in Europe. After the war, Keys became interested in tracing the causes and prevention of cardiovascular diseases, initiating studies that included the landmark epidemiologic “Seven Countries Study” showing the correlation of dietary saturated fat to heart disease. He named and evaluated body mass index (BMI) and with his wife also introduced the Mediterranean Diet.

Puska formerly held the position of Director General of Finland’s National Institute for Health and Welfare from 2009 to 2013, and currently is a professor at University of Helsinki and University of Eastern Finland. He has twice served as a member of the Finnish Parliament, working on both its Health and Social Affairs and Education committees.

From 2001 to 2003 Puska served as the Director for Noncommunicable Disease Prevention and Health Promotion at the World Health Organization Headquarters in Geneva. At WHO, Puska directed the work on integrated prevention of NCD targeting the main risk factors (tobacco, unhealthy diet and physical inactivity) through health promotion, national programs, policy measures and regional networks. His department’s work culminated in adoption of the Global Strategy on Diet, Physical Activity and Health by the World Health Assembly in 2004.

Internationally, Puska is Past President of the International Association of National Public Health Institutes (IANPHI), and he has also served as the chair of the Governing Council of the WHO International Agency for Cancer Research (IARC) and as the President of the World Heart Federation. Domestically, Puska has served among other things as the Chancellor of the University of Turku, Chair of the Finnish University Council, Member of Board of Academy of Finland, Chair of the National Nutrition Committee and President of National Union of Finnish Students.

Among his several honors are Honorary Doctorate at St. Andrew’s University (Scotland) and Lisbon University, as well as Academician of the Russian Academy of Natural Sciences. He has received, among other recognition, WHO’s annual Health Education Award in 1990, WHO Tobacco Free World Award in 1999, the Nordic Award for Public Health in 2005, and the Rank Prize in 2008.

Puska continues his affiliation with THL, the country’s comprehensive national institute for public health and welfare under Finland’s Ministry of Health.

“Pekka Puska is deserving of this award for the creative and courageous efforts he has made throughout his career, not just for the health of the people of Finland, but people around the world,” said ACLM President Dexter Shurney, MD, MBA, MPH, FACLM, DipABLM. “He is a giant in cardiovascular research and policy. Like Ancel Keys, Professor Puska has impacted and saved the lives of so many as a leader and contributor to public health and policy. We are honored to have Pekka Puska be our first Dr. Ancel Keys Award recipient.”

ABOUT THE AMERICAN COLLEGE OF LIFESTYLE MEDICINE: ACLM is the medical professional association for those dedicated to the advancement and clinical practice of Lifestyle Medicine as the foundation of a transformed and sustainable health care system. Lifestyle Medicine involves the use of the use of a whole food, plant-predominant dietary lifestyle, regular physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connection as a primary therapeutic modality to prevent, treat, and, oftentimes, reverse the lifestyle-related, chronic disease that’s all too prevalent. ACLM addresses the need for quality education and certification, supporting its members in their individual practices and in their collective desire to domestically and globally promote Lifestyle Medicine as the first treatment option, as opposed to a first option of treating symptoms and consequences with expensive, ever-increasing quantities of pills and procedures. Join today at http://www.LifestyleMedicine.org.

Share article on social media or email:

Science: Biology

Shady Grove Fertility (SGF) Improves Treatment Outcomes and Helps More Couples Conceive through Cutting-Edge Clinical Research

Leave a comment


https://www.prweb.com/

Cells under microscope

“It is one of the core values of our practice to constantly refine treatment protocols and understand treatment outcomes so that we can help more people achieve the goal of a successful pregnancy.”


WASHINGTON (PRWEB)

Physician-scientists from Shady Grove Fertility (SGF)—a premier fertility and IVF center—presented new information that helps to improve treatment outcomes for the one in eight couples who face infertility at this year’s premier education and research meeting for reproductive medicine. Held from October 12 to 16, 2019, in Philadelphia, PA, the theme of this year’s Scientific Congress of the American Society for Reproductive Medicine was “Celebrating 75 Years of History and Innovation.” The program featured scientific, postgraduate, and video presentations as well as plenary lectures addressing the most pressing clinical and basic-science issues in reproductive medicine. The meeting drew nearly 10,000 attendees from 94 countries to share their clinical research and study findings from the past year.

For the past 28 years, the physicians at SGF have placed a high value on conducting clinical research and remain a leader in the field. It is one of only a few private practice fertility centers in the country to employ a full-time dedicated research team who perform under the direction of Director of Research, Kate Devine, M.D., board certified reproductive endocrinologist who sees patients in SGF’s Washington, D.C., K Street location.

“This conference offers physicians in our field from around the world a unique opportunity to collaborate and learn from each other,” explained Dr. Devine. “With a common goal of improving treatment outcomes for patients across the globe, SGF is able to share its findings so that others can benefit. Learning from each another’s research stirs innovation and helps us sow seeds that turn into new ideas for next year’s research endeavors,” Devine added.

Among the findings SGF presented this year, two of the most notable included a new study that evaluated the optimal oral medication type (letrozole compared to clomiphene citrate, or clomid) and dose in controlled ovarian hyperstimulation/intrauterine insemination (COH / IUI) cycles to increase clinical pregnancy rates (CPR) while lowering risk of multiple gestation, i.e., twins or triplets.

The data suggested that in ovulatory women, a starting dose of 50mg of clomid provides a greater chance of a singleton gestation than a higher starting dose. Simply put, more medication doesn’t always mean better success rates, and a higher dose increases a woman’s risk of multiples.

The data also showed, in the overall population, clinical pregnancy rates were comparable between patients who received letrozole and women given clomid. However, in women who are anovulatory (do not ovulate) specifically, there was a lower chance of a multiple pregnancy when given letrozole compared to clomid. In women who are ovulatory, neither medication showed a higher risk of multiples or a higher clinical pregnancy rate than the other.

“To maximize clinical pregnancy rates while minimizing the chance of multiples in oral ovulation induction/intrauterine insemination cycles, medication and dose should be chosen carefully. Our research sheds an important light on this popular treatment approach, making it safer for women by lowering their chances of high-risk, multiple gestation pregnancies while optimizing pregnancy rates,” said Devine.

This retrospective study evaluated 8,911 patients who underwent 15,453 oral ovulation induction-IUI (OI-IUI) cycles from 2004-2018 at SGF.

In the second, highly notable study, SGF’s physician scientists showed women with endometriosis achieve equal success rates when using euploid blastocysts during frozen embryo transfers compared to couples with other diagnoses—a significant finding as this challenges decades of fertility myth that suggested women with endometriosis don’t have the same success using fertility treatments.

Conducted in partnership with the National Institutes of Health’s (NIH) National Institute of Child Health and Human Development (NICHD), SGF’s research gives hope to the nearly 10% of women who have endometriosis.

“We wanted to understand whether endometriosis, which may decrease a couple’s chances of conceiving naturally, also decreases their chances of having a baby from IVF, as many believe. Furthermore, we wanted to understand ‘why’. Was it that these women didn’t have the same rate of genetically normal embryos? Or that they have impaired endometrial receptivity preventing them from achieving or keeping a pregnancy?” explained Dr. Devine.

This retrospective study looked at 472 frozen embryo transfers in SGF patients using chromosomally normal blastocysts (as shown by preimplantation genetic testing for aneuploidy [PGT-A]). Three subsets of patients were included: women with surgically proven endometriosis, patients with isolated male factor infertility, and non-infertile patients electing genetic testing for a single gene disorder. The male factor infertility and single gene groups of patients were selected for comparison, as they typically yield strong pregnancy and delivery rates using IVF and because neither egg nor uterine infertility factors were likely to be present.

The results from the study showed that women with endometriosis had statistically similar rates of pregnancy and live birth compared to the other groups. Further, when patients with endometriosis were compared to each control group, there was no difference in the number and frequency of chromosomally normal blastocysts with PGT-A.

“We are excited to see that even though women with endometriosis may have impaired fertility, their diagnosis is not limiting them in their success with IVF treatment,” explained Devine.

“Patients can be reassured that their chances of a live birth are good when a euploid blastocyst is available. I’m encouraged for women and what this means for how we treat endometriosis. Along with advancements that we continue to make across the board, this study should encourage women with endometriosis that it’s very possible to build their family with the right treatment and timely care,” added Devine.

To learn more about ongoing research being conducted at SGF, visit http://www.shadygrovefertility.com/research

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 36 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Technology: Computer

Mushroom Networks Sets Networks on Autopilot Furthering the Human vs. Machine Saga

Leave a comment



SAN DIEGO (PRWEB)

Mushroom Networks, Inc. announced today a new set of capabilities that further automates networks via their cognitive SD-WAN routers. The new mechanisms can intelligently understand flow patterns, identify traffic types and accordingly adjust real-time treatment of IP packets over the WAN networks – moving those mundane duties away from network engineers at the enterprise branches.

Mushroom Networks’ SD-WAN routers have the ability to control how packets travel over the network by taking advantage of overlay tunnels that optimize performance in real-time with respect to application types. As an example, a WAN link can be greylisted with respect to real-time traffic during a period of high latency, while still being utilized for file transfers during the same period. These types of capabilities enable IT managers to automate traffic flow to WAN assignments providing dynamic management of those WAN resources on an on-going basis without costly and error-prone human involvement.

SD-WAN and IT automation have been widely regarded as a rising threat to human jobs as they can significantly reduce or completely eliminate many traditional IT tasks. “The new capabilities offload the manual analysis and never-ending network debugging work from the network engineer’s plate and automates that piece of the job”, said Dr. Jay Akin, CEO of Mushroom Networks. In fact, as more parts of network management are automated, job requirements for network engineering are shifting from daily routine tasks, including putting out daily fires, to high-level and forward-looking design projects.

Regarding the feared (but largely unjustified) threat that SD-WAN and IT automation jeopardize the jobs of IT professionals, Dr. Akin added, “Similar arguments were made about carriage drivers when cars were first invented, but I can safely argue that there are more professional vehicle drivers today than there were carriage drivers”.

About Mushroom Networks

Mushroom Networks, Inc., is a privately held company based in San Diego, CA, patented Broadband Bonding SD-WAN solutions to a wide range of Internet connection applications. Their products bond dissimilar broadband access technologies forming a single highly reliable broadband pipe that can easily be scaled and customized based on needs. The company’s flagship product line serves SMBs, enterprises, multi-tenant buildings, Internet Service Providers and Managed Service Providers. Mushroom Networks was the winner of the 2019 Communications Product of the year by TMC, 2017 SD-WAN excellence award by Internet Telephony Magazine, 2016 Company of the year award by Quadrant Research, 2015 Most Innovative Product award by CONNECT, finalist for the coveted 2012 San Diego Business Journal Innovation Award and winner of the XCHANGE Tech Innovators Xcellence Award. For more information, please visit https://www.mushroomnetworks.com or call (858) 452-1031.

Share article on social media or email:

Technology: Electronics

Evigence and Jarja Floral Partner to Redefine Floral Freshness Monitoring

Leave a comment


Flower Merchandising Aid

FMA Color Changing Sensors

It is incredibly difficult for consumers and retail employees to determine a floral bouquet’s remaining vase life, but no one wants to sell or buy flowers that are past their prime


HOBOKEN, N.J. and SIMCOE, Ontario (PRWEB)

PMA Fresh Summit, Booth #126 – October 17, 2019 – Evigence Sensors™ and fresh-cut tulip supplier Jarja Floral today announced the launch of a sensor specifically designed for the floral industry. Developed in partnership by Evigence and Jarja, the new Floral Merchandising Aid (FMA™) Sensor will be unveiled at the PMA Fresh Summit, Booth #126 in Anaheim, California. Leading supermarket chains are piloting the sophisticated freshness sensors on bouquets in select locations to reduce waste and increase customer satisfaction by ensuring optimum merchandising at point of purchase.

“It is incredibly difficult for consumers and retail employees to determine a floral bouquet’s remaining vase life, but no one wants to sell or buy flowers that are past their prime,” said John Oosterveld, president, Jarja. “Until now, there was no way to properly measure floral freshness to appropriately merchandise a bouquet. The FMA Sensor makes it easy for retailers and consumers to know the precise freshness of a floral arrangement.”

Designed to visually indicate the remaining saleable life of a perishable product, the latest addition to Evigence’s growing lineup of color-changing, intelligent sensors will help floral retailers better monitor and manage the merchandising of their bouquets. Like all Evigence sensors, the FMA™ Sensor takes the form of printed, self-adhesive labels in a variety of shapes and sizes that can be customized to a meet the shelf-life profile of all fresh-cut flowers.

“The extension of our sensor technologies to floral freshness was a natural fit. Like food, flowers have a short shelf life that is heavily influenced by temperature fluctuations during storage, transport and display,” added Yoav Levy, CEO, Evigence. “Floral retailers will no longer be forced to depend on a date code that cannot tell them when a bouquet is past its prime. Our new FMA Sensor gives retailers an accurate view of the bouquet’s saleable life from the time it arrives to the time of sale so they can better merchandise their stock—increasing sell through and eliminating waste.”

Changing color to indicate current freshness based on proprietary technology that monitors temperature and other freshness factors, the FMA Sensors are now available to retailers around the globe and can be calibrated for varying floral life spans. Barcodes, prices, date codes, and product origin information can also be printed on the FMA, offering transparency throughout the bouquet’s journey from producer to retailer and into a consumer’s home.

For more information on Evigence Floral Merchandising Aid and related options, please visit https://evigence.com/flowers or FMA Flowers, our FMA Sensors North American Distributor at http://www.fmaflowers.com.

About Evigence Sensors

Evigence Sensors™ is redefining how the shelf life of perishable products is monitored with an innovative lineup of small, low-cost sensors. Powering the smart consumption era, its Visual Freshness Sensors offer brands, retailers and consumers a new way to monitor freshness in real time to ensure that products are consumed at their optimal quality while decreasing waste. For more information contact, visit evigence.com.

About Jarja Floral International Corp

Jarja Floral is a producer of fresh cut tulips to the North American retail market and floral distributors for 15 years and has been cooperating with large retail market buyers to develop strategies to enhance sell-through and reduce waste. Visit us at: http://www.Jarjafloral.com.

About FMA Flowers Inc

FMA Flowers Inc is the North American distributor of the FMA Sensor developed in cooperation with Evigence. FMA Flowers also provides solution for joining the FMA sensors and applying them to the sleeves in a cost effective manner. Visit us at: http://www.fmaflowers.com.

Share article on social media or email:

health and fitness

Tel Aviv to Host 2020 Global Wellness Summit

Leave a comment


News Image

Set against the backdrop of this city’s ancient history is a thriving start-up culture of innovators and entrepreneurs who are at the epicenter of creating positive disruption through the intersection of healthcare, wellness and technology.


Singapore (PRWEB)

The Global Wellness Summit (GWS), the foremost gathering of international leaders in the $4.5 trillion global wellness economy, closed its 2019 conference by announcing that next year’s event will take place in Tel Aviv, Israel, a city bursting with historical and spiritual significance and bustling with innovations that intersect wellness, healthcare and technology. The dates for the 14th annual conference will be November 10–13, 2020. Registration for the 2020 Global Wellness Summit is now open; details can be found here.

A consortium of companies—both inside and outside of Tel Aviv—will serve as host sponsors for next year’s event. The first companies to sign on include Welltech1, a wellness innovation hub and microfund in Tel Aviv; Comtecgroup, an international event production company specializing in medical/scientific conferences; and Geneva-based L.RAPHAEL and R.RAPHAEL in Israel, a well-known luxury beauty brand and technological innovator in anti-ageing skin care.

In making the announcement, Susie Ellis, GWS chair and CEO, told delegates, “We’re thrilled to announce that the Summit will take place in this extraordinary location—one with deep spiritual significance and also firm roots in wellness, including its proximity to the Dead Sea, one of the earliest known wellness destinations.”

Nancy Davis, GWS chief creative officer and executive director, added, “Set against the backdrop of this city’s ancient history is a thriving start-up culture of innovators and entrepreneurs who are at the epicenter of creating positive disruption through the intersection of healthcare, wellness and technology.”

Davis noted that Israel, which is home to the highest concentration of start-ups after Silicon Valley and is known for its cutting-edge technology, is often referred to as “The Start-up Nation.” With this backdrop, the GWS announced plans for the 2020 Summit to include an Innovation Pavilion, which will give delegates the opportunity to meet with the many and varied start-ups working in the wellness industry in Tel Aviv and the wider world.

Welltech1’s co-founder Amir Alroy will play a key role in the Innovation Pavilion. Alroy said, “GWS delegates can expect a curated look at some of the very best wellness start-ups.”

“Israel is home to massive wellness and beauty innovations, and Israeli consumers are consistently among the earliest adopters of cutting-edge wellness-related products and services,” said Israeli-born Ronit Raphael, founder and president of Swiss-based L.RAPHAEL and R.RAPHAEL, which opened the world’s first-ever medical cosmetic center in Israel in 1986. “With a population that is expected to double over the next 30 years, Israel will no doubt lead future global wellness trends, making the country a perfect choice for next year’s Summit.”

The Global Wellness Summit is the world’s largest conference on the business of wellness and is an invitation-only event. Registration is now open, and first-time delegates should apply to attend as soon as possible.

For sponsorship opportunities, contact Michelle Gamble: michelle.gamble@globalwellnesssummit.com.

About the Global Wellness Summit: The Global Wellness Summit is an invitation-only international gathering that brings together leaders and visionaries to positively shape the future of the $4.5 trillion global wellness economy. Held in a different location each year, Summits have taken place in the US, Switzerland, Turkey, Bali, India, Morocco, Mexico, Austria and Singapore. The 14th annual Summit will take place in Tel Aviv from November 10–13, 2020.

Share article on social media or email:

Industry: Healthcare

6L Global Makes Massive Headway in the CBD Market

Leave a comment


“We can expect to see our current brand partners grow by 20-26%…”


NEW YORK (PRWEB)

6L Global, a worldwide distributor and brand developer, has seen tremendous success in the CBD market, especially with retail stores. The company has just partnered with a newly launched CBD brand and have been aggressively distributing it across the U.S. to retailers and holistic shops.

The CBD market is expected to hit $20 billion by 2024, and 6L Global has big plans to contribute to that growth by marketing the current partners they are working with and providing them with substantial distribution opportunities.

“It’s really stimulating for us when we start dabbling in a new booming market. It makes us more excited about the brands we partner with, which in turn gets them excited about the opportunity. That energy is essential to kick off a successful partnership. It’s a win-win situation all around. We can expect to see our current brand partners grow by 20-26% in their retail sales within the first fiscal quarter of 2020 by leveraging our CBD distribution capabilities alone. Once we add in our digital marketing campaigns, we’ll start to see the same growth for them on the ecommerce side.” says their Vice President of Sales.

Aside from distribution, 6L Global plans to offer their cannabinoid partners monumental growth in digital presence by broadening their online consumer reach and analyzing the structure of their e-commerce platform.

About 6L Global Corporation

6L Global helps build and launch brands, streamline manufacturing capabilities and distribute products globally by harnessing their extensive network of retailers around the world. They inspire brand owners to take the next step in strengthening their foundation, dominating their industry and skyrocketing their revenue.

To learn more about their services, visit http://www.6lglobal.com.

Safe Harbor Statement: This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934; and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and as such are by definition; subject to risks and uncertainties.

Share article on social media or email:

Health: Mental Health

TryCycle Data Systems Secures $150K Investment from Connecticut Innovations

Leave a comment


News Image


OTTAWA, Ontario (PRWEB)

TryCycle Data Systems, developer of clinician-focused software systems to address the growing epidemic of substance use, addiction and mental health, today announced that the company has secured a $150,000 pre-seed investment from Connecticut Innovations (CI), the state’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. TryCycle intends to leverage the investment to accelerate growth, create jobs in Connecticut and scale its business in the United States.

“As a home-grown Connecticut initiative, we could find no better partner than Connecticut Innovations to support our vision and grow our business,” said John MacBeth, TryCycle CEO and Founder. “Charity begins at home and, together with CI, we are now positioned to go beyond and outside the borders of Connecticut to make the greatest impact on people affected by the opioid crisis.”

TryCycle is a HIPAAA-compliant healthcare technology aiming to transform the way clinicians deliver care to patients with substance use disorders. The company’s connected health platform has been adopted by clinics and treatment centers across the state, increasing patient engagement, supporting long-term recovery outcomes and saving lives.

“Connecticut’s proximity to major cities like Boston and New York, along with the ability to access the third-most educated workforce in the nation, provides massive potential for success and long-term sustainability of TryCycle,” added MacBeth.

CI’s Pre-Seed Fund supports the formation of new Connecticut technology companies by providing the funding, mentoring and resources to help early-stage companies grow. TryCycle is also a proud member of the UConn Technology Incubation Program (TIP) and is actively working with the University of Connecticut on a global health and development research project to identify the triggers and reduce the stigma of mental health disorders.

About TryCycle:

TryCycle is unique ‘digital compassionate tether’ technology, helping to bridge the gap between the time a patient leaves treatment and their next appointment. An AI-driven data platform, TryCycle is utilized by opt-in patients who agree to participate in the program as an extension of their treatment. Patient driven data insights, trends, and risk patterns are continuously collected and analyzed in real time, to enable behavioral health interventions and clinical actions. For more information, please visit http://www.trycycledata.com.

Share article on social media or email:

Business: Insurance

Gilsbar Announces Innovative Partnership to Reduce Elective Orthopedic Surgical Spend

Leave a comment


Gilsbar’s self-funded clients now have access to the Regenexx procedures, which can effectively intervene on 70% orthopedic injuries and conditions where surgery was previously the only solution.


COVINGTON, La. (PRWEB)

Gilsbar is proud to continue our history of providing innovative and cost-effective solutions to our clients by announcing a partnership with Regenexx, a world-class interventional orthopedic clinic network which offers access to a less invasive and less costly solution for orthopedic conditions. This new benefit significantly reduces the high cost of musculoskeletal care in a healthcare plan.

Gilsbar’s self-funded clients now have access to the Regenexx procedures, which can effectively intervene on 70% orthopedic injuries and conditions (elective orthopedic surgery without fracture related care and acute care trauma) where surgery was previously the only solution. This interventional approach enables employers to save up to 70% on their orthopedic costs while providing best-in-class surgery alternatives with Regenexx’s proprietary orthobiologic procedures. Employers who partner with Regenexx not only report a remarkable drop in employees’ need for orthopedic surgery, they show less absenteeism.

“After a thorough review of the Regenexx Corporate Program, we added it as an option for our employees and our clients. Our clients now have access to add this cost-savings strategy and Best-In-Class care – a true WIN/WIN for all involved” says Brian Connelly, Director of Product Development & Strategy. “The Regenexx Corporate program aligns with Gilsbar’s commitment to lower costs, improve health, and simplify the experience for our clients and their members.”

“The Regenexx Corporate Program has quickly become an essential part of our partners healthcare plan as we help employers improve their musculoskeletal care model and strategically decrease the number of avoidable orthopedic surgeries occurring year after year. We look forward to partnering with Gilsbar and their clients to offer them this solution that employees choose over surgery a majority of the time when given the choice,” says Jason Hellickson, CEO Regenexx.

About Gilsbar, LLC

Established in 1959, Gilsbar, LLC® is one of the largest privately-held insurance services organizations in the country. Recognized as a catalyst for creating healthy businesses, Gilsbar, LLC® offers self-funded and fully-insured benefit plan management services, along with Wellness, Advocacy, and overall Population Health Management. Gilsbar, LLC’s integrated delivery model improves the health and well-being of its members, resulting in significant health plan savings for its clients.

Gilsbar, LLC® has been honored by Inc. magazine for its sustained growth, Modern Healthcare and Business Insurance magazines as a Best Place to Work, and WELCOA and the American Heart Association for its proven wellness methodology.

For more information, visit http://www.Gilsbar.com.

About Regenexx

Regenexx is a nationwide network of physicians who practice Interventional Orthopedics, a new specialty that focuses on using the most advanced regenerative protocols available as an alternative to many orthopedic surgeries. Regenexx has published roughly half of the research world-wide on the use of orthobioligics for treating orthopedic injuries, and our patented treatment lab-processing and treatment protocols allow us to achieve unmatched results. Our procedures use your body’s natural healing agents including blood platelets and bone marrow concentrate to repair damaged bone, muscle, cartilage, tendons, and ligaments. We believe in educating patients, offering options, and encouraging people to take an active role in their own treatment.

For more information on Regenexx Corporate visit http://www.RegenexxCorporate.com or call 888-547-6667.

For more information on the Regenexx procedures visit http://www.Regenexx.com     

Watch a quick introduction to Regenexx: https://www.youtube.com/watch?v=6lehuGFZP3Q&t=9s

Share article on social media or email:

Business: Executives

Contemporary Staffing Solutions Promotes Evan Violette & Alyssa Mastrangelo of PSG

Leave a comment


News Image

CSS is honored to have Evan and Alyssa leading PSG and wishes for their continued success as well as the success of every other CSS employee. We are looking forward to the continued growth and development of our team as we celebrate 25 years of business!


MOUNT LAUREL, N.J. (PRWEB)

CSS would like to recognize two employees for their recent promotions: Evan Violette and Alyssa Mastrangelo. As of 2019, Evan has earned a seat at and been promoted to the Executive Team as the Managing Director of CSS PSG. Alyssa has moved into the newly created position of Director of Recruiting for PSG.

Professional Staffing Group, typically referred to as PSG, is a business unit of Contemporary Staffing Solutions. PSG focuses on the talent acquisition of Accounting & Finance, Human Resources, Marketing, and Call Center & Office positions.

Evan Violette is dedicated to the growth of CSS and has been since he first came aboard the CSS team as an Account Executive in 2012. Not only has Evan exceeded his client relationship goals while at CSS, he has also been promoted multiple times, now wearing the esteemed title of Managing Director. In recognizing Evan’s accomplishments and skill in developing quality, effective relationships with clients, the executive team of CSS has invited Evan to join them at the highest-level decision-making table.

“Evan has the highest level of integrity and is a true partner in every sense of the word. His methodology of selling is full transparency, which always leads to strategic partnerships,” says Steve Pearson, CSO of CSS.

“Evan consistently delivers high quality solutions every day. He and his team take great care of our customers and employees,” says Mike Pearson, President of Contemporary Staffing Solutions.

Alyssa Mastrangelo has been in every operational seat in the King of Prussia, PA office. She has been dedicated to handling the intake of CSS clients’ needs by prioritizing the development of the recruiting staff and the coordinators surrounding that pivotal role. Alyssa has been on the PSG Leadership team for more than two and half years, influencing the direction of PSG with a laser focus on developing internal staff and placing the best candidates for clients. In her new role as Managing Director, Alyssa will be overseeing six offices and report directly to Evan Violette.

“Alyssa is stepping into a new role on the PSG team and I am extremely confident in her ability to accelerate the delivery of fabulous candidates to our clients,” says Sharon Tsao, CMO of Contemporary Staffing Solutions.

“Alyssa is driven by doing what is right at all times for the client, candidate, and CSS employees. She moves at an urgent speed with a strong attention to detail,” says Steve Pearson.    

CSS is honored to have Evan and Alyssa leading PSG and wishes for their continued success as well as the success of every other CSS employee. We are looking forward to the continued growth and development of our team as we celebrate 25 years of business!

About Contemporary Staffing Solutions

Contemporary Staffing Solutions (CSS) is a company that exudes unwavering results with urgency, honesty, and integrity. CSS has been a leading provider of contract, temporary, and direct hire solutions. Nationally supporting Salesforce Projects & Managed Services and staffing solutions with a focus in Accounting & Finance, Human Resources, Sales & Marketing, Information Technology, Salesforce, and Call Center & Office. Everyone at CSS operates with pro-active pipelines, the highest business ethics, a winning spirit in our approach, and a team-oriented workflow with real cross-training. The CSS team coaches you with current business intelligence so that we can timely deliver solutions to meet your expectations. Our testimonials on our website tell the story from our clients and candidates—check them out!

Share article on social media or email:

Health

Allerio Launches New Secure Mobile Hub Enabling Seamless Rich Data Integration From The Field To The ER

Leave a comment


https://www.prweb.com/

The Smart EMS Solution

“We are excited to partner with the Public Safety Network to leverage P3’s communications engineering expertise to bring an innovative and comprehensive approach to connectivity for the EMS community,” – Marc Althoff.


DULUTH, Minn. (PRWEB)

Created by former FirstNet senior executives and P3 Group North America engineers, Allerio is a smart mobile connectivity company that is taking emergency medical services (EMS) and telemedicine to the next level with next generation connectivity solutions built with meeting the needs of responders in mind. The start-up is dedicated to bringing the best technology for first responders to meet the current and future needs of the global public safety community.

Allerio is a joint venture between the Public Safety Network, LLC (PSN) and P3 North America Inc. (P3 NA) and was founded in 2019. Allerio is headquartered in Duluth, Minnesota with satellite offices spanning the U.S., including production facilities in Madison Heights, Michigan. The co-founders of PSN, TJ Kennedy, former President of the FirstNet Authority, and Jason Karp, former Chief Counsel of the FirstNet Authority, founded PSN to help bring to market the best technology and communications solutions to meet the mission critical needs of public safety. P3 NA is a subsidiary of P3 Group GmbH (P3 Group), which is a world-renowned engineering firm with significant success in the communications, automotive and aviation sectors. Kennedy and Karp are part of the Allerio senior executive team and serve on the Allerio board of directors, along with Dr. Samit Ghosh, the President and CEO of P3 NA, and Marc Peter Althoff, Managing Director of P3 Group.

“We are excited to partner with the Public Safety Network to leverage P3’s communications engineering expertise to bring an innovative and comprehensive approach to connectivity for the EMS community,” noted Marc Althoff.

Allerio executives came to understand even more the need for new and innovative communications solutions for EMS to assist with their lifesaving mission while at the FirstNet Authority, where the founders and other members of the FirstNet Authority consultation team engaged with first responders nationwide.

“As telemedicine has become more prevalent with the roll out of Emergency Triage, Treat and Transport (ET3) for out of hospital care being performed by EMS, the need for reliable, uninterrupted and secure, connectivity has become increasingly paramount. Allerio’s platform allows for that enhanced connectivity capability. Allerio’s ability to provide reliable patient data transmission gives EMS professionals the ability to quickly and accurately record and share crucial patient information, with a continued focus on the patient, instead of spending extra time doing manual data entry and recordkeeping,” said co-founder TJ Kennedy.

Allerio’s smart connectivity solutions for EMS agencies, healthcare professionals, and hospitals provide a reliable communication platform to facilitate the exchange of critical patient information and data from the field to the hospital. The Allerio “Mobile Hub” enables a seamless and automatic network transition to access the best available connectivity, whether in or out of a vehicle, patient home or other structure, ensuring patient data is delivered in real-time. Through an easy to use, one-button interface, Allerio gives EMS personnel an efficient and secure platform to connect devices and transmit rich data.

“Allerio is on the cusp of innovation, and we are truly excited about partnering with medical technology innovators to ensure public safety has the latest, most advanced lifesaving technologies at their fingertips,” added co-founder Jason Karp.

Empowering EMS with lifesaving technology is Allerio’s foundation. For all first responders who rely on broadband LTE networks to send patient data reliably to hospitals, Allerio will increase their capabilities and enable improved communications every day and during disasters to continually provide earlier medical interventions to help achieve improved patient outcomes.

For more information, visit: http://www.Allerio.com.

About TJ Kennedy

TJ Kennedy has had a 25-year career in wireless technology and public safety and is the co-founder of the Public Safety Network. He was also President of the FirstNet Authority, where he led the organization from a start-up independent authority inside the United States government to a successful $40+ billion public private partnership.

About Jason Karp

Jason Karp brings more than 25 years of legal and business executive experience in the telecom, technology, media/advertising and public safety environments, having managed within large corporations, start-ups and the federal government. Jason is the co-founder of the Public Safety Network and was the Chief Counsel at the FirstNet Authority.

About Dr. Samit Ghosh

Dr. Samit Ghosh is President and CEO of P3 North America, Inc., the U.S. arm of the P3 Group, an international management consulting and innovative engineering solutions company. Since 2005, he has been responsible for leading the company’s growth in the U.S. automotive and aerospace industry, especially in the fields of electronics, connectivity, mobility and autonomous technologies.

Marc Peter Althoff

Marc Peter Althoff is one of the founders of the telecom branch and the Group CTO of P3 Group, an international management consulting and innovative engineering solutions company. In this role he defines the growth strategy, identifying the technology domains P3 will focus on in the near-and mid-future. While at P3, he has grown the telecom branch to more than 750 engineers, providing innovative services for major wireless carriers in the U.S. and abroad.

Share article on social media or email: